Accéder au contenu
Merck

Extracellular matrix and α

Scientific reports (2017-03-16)
Nunzia Di Maggio, Elisa Martella, Agne Frismantiene, Therese J Resink, Simone Schreiner, Enrico Lucarelli, Claude Jaquiery, Dirk J Schaefer, Ivan Martin, Arnaud Scherberich
RÉSUMÉ

Stromal vascular fraction (SVF) cells of human adipose tissue have the capacity to generate osteogenic grafts with intrinsic vasculogenic properties. However, adipose-derived stromal/stem cells (ASC), even after minimal monolayer expansion, display poor osteogenic capacity in vivo. We investigated whether ASC bone-forming capacity may be maintained by culture within a self-produced extracellular matrix (ECM) that recapitulates the native environment. SVF cells expanded without passaging up to 28 days (Unpass-ASC) deposited a fibronectin-rich extracellular matrix and displayed greater clonogenicity and differentiation potential in vitro compared to ASC expanded only for 6 days (P0-ASC) or for 28 days with regular passaging (Pass-ASC). When implanted subcutaneously, Unpass-ASC produced bone tissue similarly to SVF cells, in contrast to P0- and Pass-ASC, which mainly formed fibrous tissue. Interestingly, clonogenic progenitors from native SVF and Unpass-ASC expressed low levels of the fibronectin receptor α

MATÉRIAUX
Référence du produit
Marque
Description du produit

Sigma-Aldrich
FIBRONECTINE DE PLASMA HUMAIN, liquid, 0.1% (Solution), BioReagent, suitable for cell culture
Sigma-Aldrich
Laminin from human fibroblasts, cell culture derived, liquid, sterile-filtered